Related references
Note: Only part of the references are listed.Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications
Patrick Wuchter et al.
CYTOTHERAPY (2015)
Allogeneic Cell Therapy Bioprocess Economics and Optimization: Single-Use Cell Expansion Technologies
Ana S. Simaria et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells
Ana Valeria Gouveia de Andrade et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Fed-batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty
James Pollock et al.
BIOTECHNOLOGY AND BIOENGINEERING (2013)
Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
Moira Francois et al.
CYTOTHERAPY (2012)
Assessing commercial opportunities for autologous and allogeneic cell-based products
Devyn M. Smith
REGENERATIVE MEDICINE (2012)
Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration
Aaron R. Cooper et al.
JOURNAL OF VIROLOGICAL METHODS (2011)
The Systematic Production of Cells for Cell Therapies
Daniel C. Kirouac et al.
CELL STEM CELL (2008)
Decision-support tool for assessing biomanufacturing strategies under uncertainty: Stainless steel versus disposable equipment for clinical trial material preparation
SS Farid et al.
BIOTECHNOLOGY PROGRESS (2005)
New developments in affinity chromatography with potential application in the production of biopharmaceuticals
CR Lowe et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2001)
Share Paper
